At which stage of chronic kidney disease should dyslipidemia be treated?

Nat Clin Pract Nephrol. 2006 Apr;2(4):176-7. doi: 10.1038/ncpneph0129.
No abstract available

MeSH terms

  • Cardiovascular Diseases / epidemiology*
  • Chronic Disease
  • Comorbidity
  • Dyslipidemias / drug therapy*
  • Dyslipidemias / epidemiology*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Kidney Diseases / epidemiology*
  • Kidney Diseases / therapy
  • Kidney Transplantation
  • Renal Dialysis

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors